1. Home
  2. Browse
  3. BrightFocus Foundation
  4. BrightFocus Foundation — Hidden RNA Alterations by Jumping Genes in Alzheimer's Disease

BrightFocus Foundation

BrightFocus Foundation — Hidden RNA Alterations by Jumping Genes in Alzheimer's Disease

Deadline
Rolling
Check the funder's page for current deadlines
Award ceiling
$25,000
Awards
Not stated
Posted
Not stated

Official announcement on the funder's site · opens the funder's page. Always confirm dates there.

Last checked against the funder's page on . Confirm the programme and its dates there.

Summary

Hidden RNA Alterations by Jumping Genes in Alzheimer's Disease BrightFocus Foundation BrightFocus is a premier funder of groundbreaking research in an urgent effort to discover cures for Alzheimer’s disease, macular degeneration, and glaucoma…

Preparing an application?

On Plus, $39 a month

  • The eligibility check against your profile: career stage, institution type, and the windows that close before the deadline does
Start with PlusSign in

Cancel any time. Browsing stays free.

Subjects

More from BrightFocus Foundation

Open now with at least two weeks to apply, soonest deadline first.

BrightFocus Foundation — Spatial Responses to Elevated Pressure in the Human Optic Nerve Head

BrightFocus Foundation

$150k
Rolling

BrightFocus Foundation — Artificial Intelligence-Guided Drug Discovery for Alzheimer's Disease

BrightFocus Foundation

$25k
Rolling

BrightFocus Foundation — Using Artificial Intelligence to Discover Genetic Risk Factors for Glaucoma Worsening

BrightFocus Foundation

$150k
Rolling

BrightFocus Foundation — Activating the Eye’s Own Nitric Oxide to Fight Glaucoma

BrightFocus Foundation

$150k
Rolling

Everything open from BrightFocus Foundation

Related by subject

Open opportunities sharing the most subjects with this one (Alzheimer's, Neurodegeneration), with at least two weeks to apply.

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

PAR-25-297National Institutes of Health5 review criteria on file

$1.5M

Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)

PAR-25-374National Institutes of Health3 review criteria on fileagency framework

$1M

Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)

RFA-AG-27-010National Institutes of Health

—

Everything open tagged Alzheimer's

Hiring in this research area now

All neuroscience jobs

Source record: https://www.brightfocus.org/grant/uncovering-transposable-element-exonization-as-a-hidden-layer-of-ad-genetics/Via the funder's site. Last checked against the source . Always confirm dates with the funder.